| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |